Streetbeat News

Regulatory

SVRA

Savara's Phase 3 IMPALA-2 trial of Molgramostim met statistical significance for primary and multiple secondary endpoints in treating autoimmune pulmonary alveolar proteinosis. The company plans to complete BLA submission in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 10:33 am

PL

Planet Labs PBC has confirmed that there are no changes to its previously issued financial guidance or targets, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 10:15 am

AMD

MSFT

NVDA

The UAE is advancing its AI ambitions with a $1.5 billion investment from Microsoft in a local AI firm, signaling deeper collaboration with the U.S. This partnership is part of the UAE's strategy to diversify its economy and become a global AI leader by 2031. The U.S. has also temporarily halted AI chip exports to the Middle East, affecting Nvidia and AMD.

Portfolio Pulse from Benzinga Neuro

June 26, 2024 | 9:48 am

SPY

TM

Toyota is recalling 145,254 vehicles in the U.S. due to an issue with the side curtain air bag deployment, as reported by Reuters citing the NHTSA.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 9:31 am

BTCUSD

LYV

SOLUSD

Metallica's official X account was hacked to promote a Solana-based memecoin called METAL, falsely claiming collaboration with Ticketmaster and MoonPay. The token's market cap spiked to $3.37 million before crashing to $30,000. This incident follows similar scams involving 50 Cent and Hulk Hogan, highlighting a trend of cybercriminals exploiting celebrity accounts for pump-and-dump schemes.

Portfolio Pulse from Aniket Verma

June 26, 2024 | 9:11 am

WENA

ANEW Medical, Inc. (NASDAQ:WENA) has been granted a European patent for its innovative neurodegenerative therapy. This patent covers the use of the Klotho gene sequence and gene delivery systems for treating cognitive and memory disorders. The company plans to expand its intellectual property portfolio into Asian markets in 2024.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 9:02 am

AZN

China has approved AstraZeneca's Tagrisso (Osimertinib) in combination with Pemetrexed and platinum-based chemotherapy for the first-line treatment of locally advanced or metastatic EGFR-mutated non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:56 am

UFO

Elon Musk has called for suing Jeff Bezos' Blue Origin after the company filed a public comment urging the FAA to limit SpaceX's Starship launches. Blue Origin's actions include capping launch rates and imposing penalties for violations. Musk criticized these moves as attempts to impede SpaceX's progress.

Portfolio Pulse from Shanthi Rexaline

June 26, 2024 | 8:16 am

IFF

International Flavors & Fragrances (IFF) has received EU-wide regulatory approval for two innovative poultry feed solutions, Axtra® XAP and Syncra® AVI, from its Danisco Animal Nutrition & Health unit. These products are designed to improve poultry production efficiency and gut health, respectively.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:01 am

EMCG

Embrace Change Acquisition Corp. (NASDAQ:EMCG) faces potential delisting from Nasdaq due to noncompliance with listing requirements, including insufficient shareholders and delayed financial reports. The company plans to appeal the decision and present a compliance plan.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 7:35 am